Table 1.

Differences in the incidence of tumor relapses following GCV treatment in vivo


Transplanted cells

No. of mice with complete remission, +GCV

No. of mice with tumor relapse after GCV treatment

Mean survival time after tumor relapse, d

Escape mechanism of independent tumors
EL-4, mock   1/5   5/5   23.0 ± 7.2   NA  
Mass culture, MO3N   0/5   5/5   19.0 ± 2.4   NA  
Mass culture, MO3TIN   2/5   5/5   26.6 ± 6.7   ND  
Clone no. 1, MO3TIN; Exp 1   5/5   2/5   35.5 ± 1.5   2 CD/CL  
Clone no. 1, MO3TIN; Exp 2   5/5   0/5   NA   NA  
Clone no. 2, MO3TIN   4/5   5/5   31.8 ± 8.2   3 CD/CL, 2 PR  
Clone no. 3, MO3TIN; Exp 1   5/5   3/5   28.3 ± 1.8   2 CD/CL, 1 PR  
Clone no. 3, MO3TIN; Exp 2   5/5   3/5   34.3 ± 6.4   ND  
Clone no. 4, MO3TIN; Exp 1   5/5   4/5   24.8 ± 1.1   4 GS  
Clone no. 4, MO3TIN; Exp 2   5/5   5/5   27.2 ± 3.4   5 GS  
Clone no. 5, MO3TIN; Exp 1   5/5   1/5   37.0   1 PR  
Clone no. 5, MO3TIN; Exp 2   5/5   0/5   NA   NA  
Clone no. 6, MO3TIN
 
5/5
 
2/5
 
32.5 ± 1.5
 
2 CD/CL
 

Transplanted cells

No. of mice with complete remission, +GCV

No. of mice with tumor relapse after GCV treatment

Mean survival time after tumor relapse, d

Escape mechanism of independent tumors
EL-4, mock   1/5   5/5   23.0 ± 7.2   NA  
Mass culture, MO3N   0/5   5/5   19.0 ± 2.4   NA  
Mass culture, MO3TIN   2/5   5/5   26.6 ± 6.7   ND  
Clone no. 1, MO3TIN; Exp 1   5/5   2/5   35.5 ± 1.5   2 CD/CL  
Clone no. 1, MO3TIN; Exp 2   5/5   0/5   NA   NA  
Clone no. 2, MO3TIN   4/5   5/5   31.8 ± 8.2   3 CD/CL, 2 PR  
Clone no. 3, MO3TIN; Exp 1   5/5   3/5   28.3 ± 1.8   2 CD/CL, 1 PR  
Clone no. 3, MO3TIN; Exp 2   5/5   3/5   34.3 ± 6.4   ND  
Clone no. 4, MO3TIN; Exp 1   5/5   4/5   24.8 ± 1.1   4 GS  
Clone no. 4, MO3TIN; Exp 2   5/5   5/5   27.2 ± 3.4   5 GS  
Clone no. 5, MO3TIN; Exp 1   5/5   1/5   37.0   1 PR  
Clone no. 5, MO3TIN; Exp 2   5/5   0/5   NA   NA  
Clone no. 6, MO3TIN
 
5/5
 
2/5
 
32.5 ± 1.5
 
2 CD/CL
 

± indicates SEM; NA, not applicable; ND, not determined; CD/CL, chromosomal deletion and/or chromosomal loss; PR, postinsertional recombination; and GS, gene silencing.

or Create an Account

Close Modal
Close Modal